Lipella Pharmaceuticals Inc [NASDAQ: LIPO] jumped around 0.0 points on Wednesday, while shares priced at $0.43 at the close of the session, up 1.71%.
Compared to the average trading volume of 3.32M shares, LIPO reached a trading volume of 3935812 in the most recent trading day, which is why market watchdogs consider the stock to be active.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
What do top market gurus say about Lipella Pharmaceuticals Inc [LIPO]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for LIPO shares is $2.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on LIPO stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for Lipella Pharmaceuticals Inc is set at 0.09, with the Price to Sales ratio for LIPO stock in the period of the last 12 months amounting to 6.80. The Price to Book ratio for the last quarter was 1.93, with the Price to Cash per share for the same quarter was set at 0.15.
How has LIPO stock performed recently?
Lipella Pharmaceuticals Inc [LIPO] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.57. With this latest performance, LIPO shares dropped by -1.50% in over the last four-week period, additionally sinking by -57.09% over the last 6 months – not to mention a drop of -78.87% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for LIPO stock in for the last two-week period is set at 40.98, with the RSI for the last a single of trading hit 37.98, and the three-weeks RSI is set at 42.50 for Lipella Pharmaceuticals Inc [LIPO]. The present Moving Average for the last 50 days of trading for this stock 0.5332, while it was recorded at 0.4181 for the last single week of trading, and 0.8012 for the last 200 days.
Lipella Pharmaceuticals Inc [LIPO]: Deeper insight into the fundamentals
Lipella Pharmaceuticals Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.33 and a Current Ratio set at 4.33.
Insider trade positions for Lipella Pharmaceuticals Inc [LIPO]
There are presently around $7.87%, or 12.21%% of LIPO stock, in the hands of institutional investors.
